SpringWorks Therapeutics reports the closing of its underwritten public offering of 5,637,254 shares of its common stock at a public offering price of $51.00 per share. J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Wedbush Securities Inc. acted as co-manager for the offering … more
SpringWorks had announced October 7 the pricing of its shares (more) and October 6 the proposed offering (more).